Subclinical Hypothyroidism and Chronic Inflammation in PCOS
NCT05842096 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 158
Last updated 2025-04-15
Summary
Chronic inflammation in polycystic ovary syndrome (PCOS) may be the result of dysregulation of cytokine production (due to insulin resistance, excess visceral fat and hyperandrogenemia), i.e., overproduction of pro-inflammatory factors (e.g. TNF, IL-1, IL-6) in relation to anti-inflammatory ones (IL-10). This condition may be an important link between obesity and insulin resistance, which is crucial in the etiopathogenesis of the syndrome. However, it is not known whether it results from the tendency to accumulate adipose tissue or is a feature of the syndrome itself. Concomitant endocrinopathies, i.e. obesity, dyslipidemia, insulin resistance, diabetes and thyroid diseases, may additionally influence the activity of chronic inflammation. There is no data indicating the relationship between chronic inflammation and PCOS phenotypes, the severity of metabolic disorders, ovarian reserve and the influence of thyroid function on its activity in PCOS.
Conditions
- PCOS (Polycystic Ovary Syndrome) of Bilateral Ovaries
- Subclinical hypothyroïdism
- Hypothalamic-Pituitary-Gonadal Axis Dysfunction
Interventions
- DIAGNOSTIC_TEST
-
Measurement and comparison of leucocytosis and concentrations of CRP, procalcitonin, fibrinogen, ferritin, IL-1, IL-6, IL-10, TNF-alpha in both study arms
A venous blood sample of approximately 10 ml will be collected in the morning after 8 hours of fasting to determine and compare the above parameters of peripheral blood in both arms of the study
- DIAGNOSTIC_TEST
-
Evaluation of the impact of subclinical hypothyroidism, with present/ absent antithyroid antibodies, on the balance between anti- and pro-inflammatory factors in women in both study arms
A venous blood sample of approximately 10 ml will be collected in the morning after 8 hours of fasting to determine and compare blood levels of leukocytosis, CRP, procalcitonin, fibrinogen, ferritin, IL-1, IL-6, IL-10, TNF-alpha depending on the blood concentrations of TSH, a-TPO and a-TG in women in both study arms
- DIAGNOSTIC_TEST
-
Assessment of the impact of imbalance between anti- and pro-inflammatory factors in women with different PCOS and HPOD phenotypes on ovarian reserve indices
A venous blood sample of approximately 10 ml will be collected in the morning after 8 hours of fasting to determine and compare blood levels of leukocytosis, CRP, procalcitonin, fibrinogen, ferritin, IL-1, IL-6, IL-10, TNF-alpha and AMH, FSH in women in both study arms
Sponsors & Collaborators
-
Jagiellonian University
lead OTHER
Principal Investigators
-
Robert Jach, Prof., Ph.D. · Jagiellonian University
Study Design
- Allocation
- NON_RANDOMIZED
- Purpose
- DIAGNOSTIC
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Max Age
- 45 Years
- Sex
- FEMALE
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2024-01-01
- Primary Completion
- 2024-12-30
- Completion
- 2024-12-30
Countries
- Poland
Study Locations
More Related Trials
-
IR, Inflammatory and Cardiovascular Markers in PCOS Among Obese and Non-obese Women
NCT01989039 ·Status: UNKNOWN
-
Periodontal Status and Endothelial Dysfunction in Patients With Polycystic Ovary Syndrome
NCT06184412 ·Status: COMPLETED
-
Subcutaneous Adipose Tissue in Cases With Polycystic Ovarian Syndrome
NCT01310569 ·Status: COMPLETED
-
Epicardial Adipose Tissue Thickness in Polycystic Ovary Syndrome (PCOS)
NCT01258946 ·Status: COMPLETED
-
Expression of CVD and HA Between Obesity and Non-obesity Polycystic Ovary Syndrome (PCOS) Women in Taiwan
NCT01113918 ·Status: COMPLETED
-
Adipocytokines and Polycystic Ovary Syndrome (PCOS)
NCT00975832 ·Status: COMPLETED
-
Adipose Expression of Leptin, Adiponectin and IL-6 and Plasma Levels of Adipocytokines in Women With and Without Polycystic Ovary Syndrome (PCOS)
NCT01088061 ·Status: COMPLETED
-
Serum Anti-Mullerian Hormone (AMH) Levels in Overweight and Obese Adolescent Girls With Polycystic Ovaries
NCT01856894 ·Status: COMPLETED
-
Endocrine, Metabolic and Inflammatory Characteristics of Offspring of Mothers With PCOS Hyperandrogenism
NCT06371313 ·Status: COMPLETED
-
Adipokines in Polycystic Ovary Syndrome
NCT06793072 ·Status: RECRUITING
-
The Effect of Ibuprofen on Women With PCOS.
NCT04485403 ·Status: UNKNOWN ·Phase: PHASE2
-
Changes in Serum, Follicular Fluid SREBP1c and LRG1 Levels in PCOS Patients and Correlation With Insulin Resistance
NCT06066034 ·Status: UNKNOWN
-
Resting Metabolic Rate, Fat Distribution, Endocrine and Metabolic Features in Polycystic Ovary Syndrome
NCT03132545 ·Status: COMPLETED
-
Evaluation of Anti-mullerian Hormone(AMH) Levels as a Predictive Factor of Response to Weight Loss Treatment in Obese Infertile Women With Poly Cystic Ovary(PCOS)
NCT01792362 ·Status: COMPLETED ·Phase: PHASE3
-
Evaluation of Periodontal Status and hsCRP Levels in Females With PCOS on CPA/EE Combination Drug Regimen
NCT05021861 ·Status: UNKNOWN
-
Presentations of Hyperandrogenic Phenotypes in Taiwanese Women
NCT01940666 ·Status: COMPLETED
-
Prevalence of Hyperandrogenism in Type 1 Diabetes
NCT04979377 ·Status: COMPLETED
-
Quality of Life in Normogonadotropic Anovulation
NCT06208995 ·Status: COMPLETED
-
PCOS, Therapy and Markers of Cardiovascular Risk
NCT01798875 ·Status: UNKNOWN ·Phase: PHASE4
-
Ovarian Hyperandrogenism in Normal and Excessive Body Weight Adolescent Girls and Their Relation to Diet (HAstudy)
NCT04738409 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Association of Vitamin D Status With Metabolic Markers in Adolescents With Polycystic Ovary Syndrome
NCT06970821 ·Status: COMPLETED
-
Ovarian Reserve in Patients With Psoriasis
NCT03492632 ·Status: COMPLETED
-
Post-Prandial Liver Glucose Metabolism in PCOS
NCT03041129 ·Status: COMPLETED
-
LH/FSH, Testosterone, Prolactin, and Ferritin in PCOS Patients in Jordan
NCT07112768 ·Status: COMPLETED
-
The Secretion of Incretin Hormones in Patients With Polycystic Ovary Syndrome
NCT02126592 ·Status: UNKNOWN